These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
418 related items for PubMed ID: 16430654
1. Intravesical instillation of human urine after oral administration of trospium, tolterodine and oxybutynin in a rat model of detrusor overactivity. Kim Y, Yoshimura N, Masuda H, De Miguel F, Chancellor MB. BJU Int; 2006 Feb; 97(2):400-3. PubMed ID: 16430654 [Abstract] [Full Text] [Related]
2. Antimuscarinic agents exhibit local inhibitory effects on muscarinic receptors in bladder-afferent pathways. Kim Y, Yoshimura N, Masuda H, de Miguel F, Chancellor MB. Urology; 2005 Feb; 65(2):238-42. PubMed ID: 15708029 [Abstract] [Full Text] [Related]
3. Urodynamic effects of oxybutynin and tolterodine in conscious and anesthetized rats under different cystometrographic conditions. Angelico P, Velasco C, Guarneri L, Sironi G, Leonardi A, Testa R. BMC Pharmacol; 2005 Oct 11; 5():14. PubMed ID: 16216132 [Abstract] [Full Text] [Related]
4. The effects of a type 4 phosphodiesterase inhibitor and the muscarinic cholinergic antagonist tolterodine tartrate on detrusor overactivity in female rats with bladder outlet obstruction. Kaiho Y, Nishiguchi J, Kwon DD, Chancellor MB, Arai Y, Snyder PB, Yoshimura N. BJU Int; 2008 Mar 11; 101(5):615-20. PubMed ID: 18070178 [Abstract] [Full Text] [Related]
5. Effects of tolterodine on an overactive bladder depend on suppression of C-fiber bladder afferent activity in rats. Yokoyama O, Yusup A, Miwa Y, Oyama N, Aoki Y, Akino H. J Urol; 2005 Nov 11; 174(5):2032-6. PubMed ID: 16217388 [Abstract] [Full Text] [Related]
6. Effects of tolterodine on afferent neurotransmission in normal and resiniferatoxin treated conscious rats. Hedlund P, Streng T, Lee T, Andersson KE. J Urol; 2007 Jul 11; 178(1):326-31. PubMed ID: 17507042 [Abstract] [Full Text] [Related]
7. Human urine with solifenacin intake but not tolterodine or darifenacin intake blocks detrusor overactivity. Chuang YC, Thomas CA, Tyagi S, Yoshimura N, Tyagi P, Chancellor MB. Int Urogynecol J Pelvic Floor Dysfunct; 2008 Oct 11; 19(10):1353-7. PubMed ID: 18504514 [Abstract] [Full Text] [Related]
8. Characterization of muscarinic receptor binding and inhibition of salivation after oral administration of tolterodine in mice. Oki T, Maruyama S, Takagi Y, Yamamura HI, Yamada S. Eur J Pharmacol; 2006 Jan 04; 529(1-3):157-63. PubMed ID: 16316647 [Abstract] [Full Text] [Related]
9. Effects on bladder function of combining elocalcitol and tolterodine in rats with outflow obstruction. Streng T, Andersson KE, Hedlund P, Gratzke C, Baroni E, D'Ambrosio D, Benigni F. BJU Int; 2012 Jul 04; 110(2 Pt 2):E125-31. PubMed ID: 22288904 [Abstract] [Full Text] [Related]
10. Effects of antimuscarinics on voiding function after cerebral infarction in a rat model of overactive bladder. Yusup A, Akino H, Miwa Y, Oyama N, Aoki Y, Ito H, Tanase K, Matsuta Y, Nakai M, Yokoyama O. Eur J Pharmacol; 2007 Dec 22; 577(1-3):143-9. PubMed ID: 17904547 [Abstract] [Full Text] [Related]
11. Comparative analysis of the effects of antimuscarinic agents on bladder functions in both nonhuman primates and rodents. Nagabukuro H, Villa KL, Wickham LA, Kulick AA, Gichuru L, Donnelly MJ, Voronin GO, Pereira T, Tong X, Nichols A, Alves SE, O'Neill GP, Johnson CV, Hickey EJ. J Pharmacol Exp Ther; 2011 Jul 22; 338(1):220-7. PubMed ID: 21459965 [Abstract] [Full Text] [Related]
14. Comparative in vivo uroselectivity profiles of anticholinergics, tested in a novel anesthetized rabbit model. Naruganahalli KS, Sinha S, Hegde LG, Meru AV, Chugh A, Kumar N, Gupta JB, Ray A. Eur J Pharmacol; 2007 Oct 31; 572(2-3):207-12. PubMed ID: 17610864 [Abstract] [Full Text] [Related]
15. Pharmacological effects of propiverine and its active metabolite, M-1, on isolated human urinary bladder smooth muscle, and on bladder contraction in rats. Sugiyama Y, Yoshida M, Masunaga K, Satoji Y, Maeda Y, Nagata T, Inadome A, Ueda S. Int J Urol; 2008 Jan 31; 15(1):76-81. PubMed ID: 18184179 [Abstract] [Full Text] [Related]
16. Effects of solifenacin succinate (YM905) on detrusor overactivity in conscious cerebral infarcted rats. Suzuki M, Ohtake A, Yoshino T, Yuyama H, Hayashi A, Ukai M, Okutsu H, Noguchi Y, Sato S, Sasamata M. Eur J Pharmacol; 2005 Apr 04; 512(1):61-6. PubMed ID: 15814091 [Abstract] [Full Text] [Related]
17. Modulation of non-voiding activity by the muscarinergic antagonist tolterodine and the β(3)-adrenoceptor agonist mirabegron in conscious rats with partial outflow obstruction. Gillespie JI, Palea S, Guilloteau V, Guerard M, Lluel P, Korstanje C. BJU Int; 2012 Jul 04; 110(2 Pt 2):E132-42. PubMed ID: 22734512 [Abstract] [Full Text] [Related]
18. Oxybutynin and propiverine suppress adenosine triphosphate-induced bladder overactivity other than through antimuscarinic mechanisms. Moon HS, Lee JW, Park SY, Son YW, Kim YT. Urology; 2010 Aug 04; 76(2):509.e8-12. PubMed ID: 20546876 [Abstract] [Full Text] [Related]
19. Comparison of the efficacy of tolterodine and oxybutynin in different urodynamic severity grades of idiopathic detrusor overactivity. Giannitsas K, Perimenis P, Athanasopoulos A, Gyftopoulos K, Nikiforidis G, Barbalias G. Eur Urol; 2004 Dec 04; 46(6):776-82; discussion 782-3. PubMed ID: 15548447 [Abstract] [Full Text] [Related]
20. Influence of estradiol pretreatment on antimuscarinic action of oxybutynin in rat detrusor muscle. Yildiz O, Ozgok Y, Seyrek M, Un I, Kilciler M, Tuncer M. Urology; 2005 Apr 04; 65(4):800-3. PubMed ID: 15833550 [Abstract] [Full Text] [Related] Page: [Next] [New Search]